Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome prediction
BACKGROUND: A multimodal AI (MMAI) model has been validated in prostate biopsy specimens to guide treatment intensification in men receiving radiation. The MMAI has been explored to an extent for prostatectomy patients and has not yet been examined in relation to established genomic scores. METHODS: We applied the MMAI biopsy model to a tissue microarray (TMA) of 424 prostatectomy cases with long-term follow-up. MMAI scores were derived from digitized pathology images and clinical variables. Associations with bi…

ace











